CT-guided Localization for Micro Hepatocellular Carcinoma Before Surgical Resection (CTMH)
Cirrhosis, Liver, Hepatocellular Carcinoma
About this trial
This is an interventional treatment trial for Cirrhosis, Liver focused on measuring Cirrhosis, hepatocellular carcinoma, localization needle
Eligibility Criteria
Inclusion Criteria:
- Be at least 18 years old and give informed consent to participate in the study
- A preoperative (clinical, radiological, or histological) diagnosis of cirrhosis of the liver due to any cause.
- micro hepatocellular carcinoma (diameter less than 1cm).
- Preoperative CT plain scan could not find the lesion, and preoperative B-ultrasound could not find the lesion.
- Preoperative CT enhancement or MRI can detect the lesion.
Exclusion Criteria:
- Child-Pugh grade C
- Uncontrolled Hypertension
- Severe lung dysfunction
- Severe cardiac dysfunction
Sites / Locations
- Clinical Medical College, Yangzhou UniversityRecruiting
Arms of the Study
Arm 1
Experimental
CT-guided localization for micro hepatocellular carcinoma before surgical resection
fter preoperative preparation was completed, on the day of surgery, disposable pulmonary nodular localization needle (Ningbo Sonjiecang Biological Technology Co., LTD., Model: SS510-10) was used for the localization of micro hepatocellular carcinoma that could be found by preoperative CT enhancement or MRI. After the micro hepatocellular carcinoma was located under the guidance of CT, and then the patient was sent to the operating room. During the operation, the lesion was removed according to the tail line of the positioning needle and the position of the positioning needle.